GALECTIN THERAPEUTICS INC — Director's Dealing 2015

Jul 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2015-03-12

Reporting Person: OMENN GILBERT S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-12	Common Stock	A	11112	—	Acquired	40121	Direct
2015-04-07	Common Stock	A	1506	—	Acquired	41627	Direct
2015-04-08	Common Stock	A	25934	—	Acquired	67561	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-08	Stock Option (right to buy)	$5.06	D	28323	Disposed	2024-09-23	Common Stock (28323)	Direct

Footnotes

F1: 25,071 options vested upon grant and 3,252 options vested ratably through February 11, 2015.

F2: The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 25,934 shares of restricted common stock, reported in Table 1 of this Form 4, as consideration for the cancellation of options granted on September 23, 2014.